ATE388958T1 - 4'-c-substituierte 2-haloadenosinderivate - Google Patents

4'-c-substituierte 2-haloadenosinderivate

Info

Publication number
ATE388958T1
ATE388958T1 AT05006326T AT05006326T ATE388958T1 AT E388958 T1 ATE388958 T1 AT E388958T1 AT 05006326 T AT05006326 T AT 05006326T AT 05006326 T AT05006326 T AT 05006326T AT E388958 T1 ATE388958 T1 AT E388958T1
Authority
AT
Austria
Prior art keywords
substituted
haloadenosine
derivative
derivatives
provides
Prior art date
Application number
AT05006326T
Other languages
English (en)
Inventor
Satoru Kohgo
Hiroshi Ohrui
Eiichi Kodama
Masao Matsuoka
Hiroaki Mitsuya
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Application granted granted Critical
Publication of ATE388958T1 publication Critical patent/ATE388958T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT05006326T 2004-03-24 2005-03-23 4'-c-substituierte 2-haloadenosinderivate ATE388958T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004087198 2004-03-24
JP2004263409 2004-09-10

Publications (1)

Publication Number Publication Date
ATE388958T1 true ATE388958T1 (de) 2008-03-15

Family

ID=34934441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05006326T ATE388958T1 (de) 2004-03-24 2005-03-23 4'-c-substituierte 2-haloadenosinderivate

Country Status (8)

Country Link
US (3) US7339053B2 (de)
EP (1) EP1589026B1 (de)
JP (2) JP4253342B2 (de)
AT (1) ATE388958T1 (de)
CA (1) CA2502109C (de)
DE (1) DE602005005240T2 (de)
ES (1) ES2300892T3 (de)
WO (1) WO2005090349A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1394597B1 (de) 2002-09-02 2011-03-23 Samsung Electronics Co., Ltd. Kontaktstruktur für eine Halbleitervorrichtung, dünnschichtige Transistoranordnung mit einer solchen Kontaktstruktur und dessen Herstellungsmethode
CA2502109C (en) * 2004-03-24 2010-02-23 Yamasa Corporation 4'-c-substituted-2-haloadenosine derivative
EP2170053A4 (de) 2007-01-31 2010-06-23 Biosuccess Biotech Company Zusammensetzungen und verfahren für die verwendung von phorbolestern
US9974764B2 (en) 2007-01-31 2018-05-22 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters in the treatment of neoplasms
US9533938B2 (en) 2007-01-31 2017-01-03 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters for the treatment of stroke
US11696908B2 (en) 2007-01-31 2023-07-11 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters
US11564901B2 (en) 2007-01-31 2023-01-31 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters
US10369222B2 (en) 2012-01-18 2019-08-06 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters for the treatment of stroke
US9636317B2 (en) 2007-01-31 2017-05-02 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters
JP4954224B2 (ja) 2007-02-13 2012-06-13 三菱電機株式会社 表示装置およびその製造方法
US10099996B2 (en) 2012-01-18 2018-10-16 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters in the treatment of neoplasms
US9550722B2 (en) 2012-01-18 2017-01-24 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbal esters for the treatment of stroke
JP6191989B2 (ja) * 2014-02-12 2017-09-06 学校法人東京理科大学 アデニン誘導体又はその薬理学的に許容しうる塩、その製造方法、及びその用途
WO2015143712A1 (en) 2014-03-28 2015-10-01 Merck Sharp & Dohme Corp. 4'-substituted nucleoside reverse transcriptase inhibitors
MA41213A (fr) * 2014-12-19 2017-10-24 Alios Biopharma Inc Nucléosides substitués, nucléotides et analogues de ceux-ci
MX391226B (es) 2015-09-23 2025-03-21 Merck Sharp & Dohme Llc Inhibidores de transcriptasa inversa de nucleosido 4'-substituido y preparaciones de los mismos.
JOP20170038B1 (ar) * 2016-02-12 2021-08-17 Merck Sharp & Dohme مركبات للاستخدام لعلاج عدوى بفيروس hiv والوقاية منه
JP6934019B2 (ja) 2016-05-12 2021-09-08 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 抗ウイルス薬を送達するための薬物送達システム
WO2017222903A1 (en) * 2016-06-20 2017-12-28 Merck Sharp & Dohme Corp. Drug delivery system for the delivery of antiviral agents
WO2018092728A1 (ja) 2016-11-16 2018-05-24 国立研究開発法人国立国際医療研究センター 抗ウイルス活性等の生理活性を有するヌクレオシド誘導体
EP3609508A4 (de) * 2017-04-10 2021-02-10 Merck Sharp & Dohme Corp. Wirkstofffreisetzungssystem zur freisetzung von antiviralen wirkstoffen
JP2020527570A (ja) * 2017-07-18 2020-09-10 ヴィーブ ヘルスケア カンパニー 組み合わせ薬物療法
US11040975B2 (en) 2017-12-08 2021-06-22 Merck Sharp & Dohme Corp. Carbocyclic nucleoside reverse transcriptase inhibitors
EP3762396A1 (de) * 2018-03-07 2021-01-13 GlaxoSmithKline Intellectual Property (No.2) Limited Verbindungen zur verwendung in der hiv-therapie
JP7402225B2 (ja) 2018-05-11 2023-12-20 ロード アイランド ホスピタル ヌクレオシド系逆転写酵素阻害剤を用いて関節障害を処置するための組成物および方法
CN109893536B (zh) * 2018-07-02 2021-04-27 河南真实生物科技有限公司 4’-取代核苷的晶型、制备和应用
JP7773906B2 (ja) 2018-07-09 2025-11-20 メルク・シャープ・アンド・ドーム・エルエルシー ４’－エチルヌクレオシド類似体の酵素的合成
AU2019317810A1 (en) * 2018-08-09 2021-02-25 Glaxosmithkline Intellectual Property (No.2) Limited Compounds useful in HIV therapy
JP2021536444A (ja) * 2018-08-30 2021-12-27 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited Ｈｉｖ療法に有用な化合物
CA3122576C (en) * 2018-12-20 2025-11-25 Merck Sharp & Dohme Llc CRYSTALLINE FORMS OF THE NRTTI COMPOUND OF 4'-ETHYNYL-2-FLUORO-2'-DESOXYADENOSINE
EP3914604B1 (de) 2019-01-25 2026-03-04 Brown University Zusammensetzungen enthaltend censavudin oder elvucitabin zur behandlung der altersbedingten entzündung und der störungen
CN113811360A (zh) * 2019-03-06 2021-12-17 葛兰素史密斯克莱知识产权（第2 号）有限公司 用于hiv治疗的化合物
WO2020263660A1 (en) 2019-06-24 2020-12-30 Merck Sharp & Dohme Corp. Process for the preparation of 2-fluoroadenine
CA3146679A1 (en) * 2019-07-27 2021-02-04 Brii Biosciences, Inc. Adenosine derivative and pharmaceutical composition comprising the same
EP4010349A1 (de) * 2019-08-08 2022-06-15 GlaxoSmithKline Intellectual Property (No. 2) Limited 4'-ethynyl-2'-deoxyadenosinderivate und ihre verwendung in der hiv-therapie
CN114206336A (zh) * 2019-08-13 2022-03-18 默沙东公司 用于递送抗病毒剂的药物递送系统
WO2021038509A1 (en) * 2019-08-28 2021-03-04 Glaxosmithkline Intellectual Property (No.2) Limited 4'-ethynyl-2'-deoxyadenosine derivatives and their use in hiv therapy
KR20220066303A (ko) 2019-09-11 2022-05-24 더 스크립스 리서치 인스티튜트 항바이러스 전구약물 및 이의 약제학적 조성물
WO2021188959A1 (en) * 2020-03-20 2021-09-23 Gilead Sciences, Inc. Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
AU2021268584A1 (en) * 2020-05-05 2022-12-01 Merck Sharp & Dohme Llc Drug delivery system for the delivery of antiviral agents and contraceptives
EP4281081A4 (de) 2021-01-25 2025-05-14 Brii Biosciences, Inc. Adenosinderivat und pharmazeutische zusammensetzung damit
EP4281083A4 (de) 2021-01-25 2025-01-01 Brii Biosciences, Inc. Kombinationstherapie für hiv mit adenosinderivat und kapsidinhibitoren
WO2022182604A1 (en) * 2021-02-23 2022-09-01 Viiv Healthcare Company Compounds useful in hiv treatment
EP4358968A4 (de) * 2021-06-22 2025-05-07 Rome Therapeutics, Inc. 4-ethinyl-3-hydroxy-tetrahydrofuranyl-adeninphosphoramidate und verwandte verbindungen und ihre verwendung bei der behandlung von medizinischen erkrankungen
IL315480A (en) 2022-03-15 2024-11-01 Rome Therapeutics Inc Compounds and methods for treating disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192749A (en) * 1990-05-21 1993-03-09 Syntex (U.S.A.) Inc. 4'-substituted nucleosides
ATE250622T1 (de) * 1999-05-12 2003-10-15 Yamasa Corp 4'-c-ethynyl-pyrimidine nukleoside
JP4076114B2 (ja) * 1999-05-12 2008-04-16 ヤマサ醤油株式会社 ４’−ｃ−エチニルプリンヌクレオシド化合物
AU2003211483A1 (en) * 2002-02-15 2003-09-04 Yamasa Corporation 4'-c-cyano-2'-deoxypurine nucleosides
CN102174038A (zh) * 2003-02-19 2011-09-07 耶鲁大学 用于治疗病毒感染的抗病毒核苷
CA2502109C (en) 2004-03-24 2010-02-23 Yamasa Corporation 4'-c-substituted-2-haloadenosine derivative

Also Published As

Publication number Publication date
JPWO2005090349A1 (ja) 2008-01-31
US20050215512A1 (en) 2005-09-29
US20090234110A1 (en) 2009-09-17
US7339053B2 (en) 2008-03-04
US7625877B2 (en) 2009-12-01
CA2502109A1 (en) 2005-09-24
CA2502109C (en) 2010-02-23
JP2011256173A (ja) 2011-12-22
DE602005005240D1 (de) 2008-04-24
ES2300892T3 (es) 2008-06-16
EP1589026A1 (de) 2005-10-26
JP5213194B2 (ja) 2013-06-19
US8039614B2 (en) 2011-10-18
WO2005090349A1 (ja) 2005-09-29
DE602005005240T2 (de) 2009-03-12
US20080153774A1 (en) 2008-06-26
EP1589026B1 (de) 2008-03-12
JP4253342B2 (ja) 2009-04-08

Similar Documents

Publication Publication Date Title
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
EP1221439A4 (de) Tetrahydroquinolin-derivate
IL156873A0 (en) Pharmaceutically active piperidine derivatives
AU3599701A (en) Fluorescent probes for the quantitation of zinc
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
ATE503746T1 (de) Neue imidazolidinderivate
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
MX2010001566A (es) Derivado de aminopirazolamida.
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
MY138826A (en) 2,7-substituted indoles
TW200744589A (en) Pharmaceutical composition
PL1845780T3 (pl) Zastosowanie pochodnych metylofenidatu
DE60239491D1 (de) Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung
WO2004009585A3 (fr) Derives d'acyloxypyrrolidine et leur utilisation en tant que ligands des recepteurs v1b et v1a de avp
EA200801139A1 (ru) Композиция для аэрозольной ингаляции
AR034313A1 (es) Utilizacion de derivados de piridoindolona para la preparacion de medicamentos
MXPA03008725A (es) Medicamentos para hiperactividad vesicular.
WO2004093796A3 (en) Lactam derivatives and methods of their use
DE602006013828D1 (en) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
AU2003235359A1 (en) Biguanide derivative and therapeutic agent for diabetes containing the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1589026

Country of ref document: EP